I accept your apology!
Haha..just kidding..
But to recap..
Three times Biogen has gone
Upwards of over $30,000,000 in market cap over possible good news regarding aduscamabsm..(injection with brain swelling?)
We actually have a safe and effective treatment..
So let’s start at $30,000,000,000..
70,000,000 shares ( added a few)
$400 per share...that is just the start..
This doesn’t include any of the following;
Not prophylactic..
Not a3-71!
Not bio system specific!
Not adjunctive therapy!
Not patent extending combo treat..
Well past the $1,000 share mark